Comment expliquer l’augmentation des thromboses chez le sujet âgé ?

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Presse Medicale

• Publication date

  2005-07-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/S0755-4982(05)84069-2
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• C-reactive protein and arterial stiffness in older adults: the Rotterdam Study.

  2004cited by this paper
• Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a "set up" for vascular disease.

  2003cited by this paper
• Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises: Part III: Cellular and Molecular Clues to Heart and Arterial Aging

  2003cited by this paper
• High plasma concentration of factor VIII coagulant is also a risk factor for venous thromboembolism in the elderly.

  2003cited by this paper
• Evidence for reduction of pro-atherosclerotic properties in platelets from healthy centenarians.

  2003cited by this paper
• Clinical application of C-reactive protein for cardiovascular disease detection and prevention.

  2003cited by this paper
• Aging and Thrombosis

  2002cited by this paper
• Hemostatic and inflammatory markers as risk factors for coronary disease in the elderly.

  2002cited by this paper
• Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis.

  2002cited by this paper
• Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study.

  2002cited by this paper
• Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study.

  2002cited by this paper
• Mycobacterium tuberculosis disease in Somali immigrants in Minnesota.

  2001cited by this paper
• Common femoral vein dimensions and hemodynamics including Valsalva response as a function of sex, age, and ethnicity in a population study.

  2001cited by this paper
• Impaired Homocysteine Metabolism and Atherothrombotic Disease

  2001cited by this paper
• Time trends in autism and in MMR immunization coverage in California.

  2001cited by this paper
• Angiogenesis Research: Guidelines for Translation to Clinical Application

  2001cited by this paper
• Changes of haemostasis in patients undergoing major abdominal surgery--is there a difference between elderly and younger patients?

  2001cited by this paper
• The Hemostatic System as a Regulator of Angiogenesis*

  2000cited by this paper
• The New England Journal

  2000cited by this paper
• Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome.

  2000cited by this paper
• Age, functional status, and racial differences in plasma D-dimer levels in community-dwelling elderly persons.

  2000cited by this paper
• Subunit antigen and activity levels of blood coagulation factor XIII in healthy individuals. Relation to sex, age, smoking, and hypertension.

  1999cited by this paper
• Homocysteine: an emerging age-related cardiovascular risk factor.

  1999cited by this paper
• The relationship of fibrinogen and factors VII and VIII to incident cardiovascular disease and death in the elderly: results from the cardiovascular health study.

  1999cited by this paper
• Homocysteine and risk of cardiovascular disease among postmenopausal women.

  1999cited by this paper
• The natural course of atherosclerosis. Part II: vascular remodeling. Bruneck Study Group.

  1999cited by this paper
• Relationship of plasmin generation to cardiovascular disease risk factors in elderly men and women.

  1999cited by this paper
• Assay of procarboxypeptidase U, a novel determinant of the fibrinolytic cascade, in human plasma.

  1999cited by this paper
• Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly.

  1999cited by this paper
• The Pathophysiologic Roles of Interleukin-6 in Human Disease

  1998cited by this paper
• Correlates of Antithrombin, Protein C, Protein S, and TFPI in a Healthy Elderly Cohort

  1998cited by this paper
• Increased carotid artery intimal-medial thickness in asymptomatic older subjects with exercise-induced myocardial ischemia.

  1998cited by this paper
• Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.

  1998cited by this paper
• EPIDEMIOLOGY OF COAGULATION FACTORS, INHIBITORS AND ACTIVATION MARKERS: THE THIRD GLASGOW MONICA SURVEY I. ILLUSTRATIVE REFERENCE RANGES BY AGE, SEX AND HORMONE USE

  1997cited by this paper
• Age‐related changes in factor VII proteolysis in vivo

  1996cited by this paper
• Hypercoagulability in centenarians: the paradox of successful aging.

  1995cited by this paper
• Fibrin degeneration product concentrations (D-dimers) in the course of ageing.

  1995cited by this paper
• Fibrinogen and factor VIII, but not factor VII, are associated with measures of subclinical cardiovascular disease in the elderly. Results from The Cardiovascular Health Study.

  1995cited by this paper
• Age and Functional Correlations of Markers of Coagulation and Inflammation in the Elderly: Functional Implications of Elevated Crosslinked Fibrin Degradation Products (D‐dimers)

  1994cited by this paper
• Protein C, antithrombin III and plasminogen: effect of age, sex and blood group

  1994cited by this paper
• Influence of age on venous physiologic parameters.

  1993cited by this paper
• Vitamin status and intake as primary determinants of homocysteinemia in an elderly population.

  1993cited by this paper
• Interleukin‐6: A Cytokine for Gerontolgists

  1993cited by this paper
• Age-dependent effect on the level of factor IX.

  1993cited by this paper
• Update on fibrinogen as a cardiovascular risk factor.

  1992cited by this paper
• The distribution of coagulation factors VII and VIII and fibrinogen in adults over 65 years. Results from the Cardiovascular Health Study.

  1992cited by this paper
• Heart disease: A textbook of cardiovascular medicine

  1992cited by this paper
• Which factors affect high D-dimer levels in the elderly?

  1991cited by this paper
• Platelet activity and phosphoinositide turnover increase with advancing age.

  1990cited by this paper
• Antithrombotic therapy for venous thromboembolic disease.

  1989cited by this paper
• Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: correlation with age and serum triglyceride concentrations.

  1987cited by this paper
• Fibrinogen and risk of cardiovascular disease. The Framingham Study.

  1987cited by this paper
• Aging-associated changes in indices of thrombin generation and protein C activation in humans. Normative Aging Study.

  1987cited by this paper
• Effects of age on ventricular-vascular coupling.

  1985cited by this paper
• Factor V in an Industrial Population

  1976cited by this paper

• The Risk of Venous Thromboembolism in Algerian Patients

  2014influential citation
• Maladie thromboembolique veineuse dans la région de Sidi Bel Abbes, Algérie: fréquence et facteurs de risque

  2013influential citation
• Nomégestrol acétate en contraception et risque thromboembolique veineux

  2012cites this paper